Scientific Programme in Details






Wednesday, May 16

  Conference Room 1
18:00 Exhibition and Registration Opening
19:00 Welcome Reception


Thursday, May 17

  Nikos Skalkotas Hall
Chairs Michel Suter, Harry Pappis
09:00-09:10 Welcome speech
  Michel Suter (Switzerland); Harry Pappis (Greece)
09:10-09:40 Plenary lecture: Treating NASH with metabolic surgery?
  François Pattou (France)
09:40-10:00 Lifestyle intervention for NAFLD/NASH
  Alexander Kokkinos (Greece)
10:00-10:20 GLP-1 receptor analogues and NAFLD/NASH
  Carel Le Roux (Ireland)
10:20-10:30 Discussion
09:40-10:30 ORAL COMMUNICATIONS: Surgical Complications
Chairs Gerhard Prager, Scott Shikora, Dimitris Zacharoulis
09:40-10:00 Introductory: When things go wrong - why patients go to lawyers
  Alberic Fiennes (UK)
10:00-10:10 O-001 Fast track surgery program (FTS) in bariatric surgery, Is it safe? (ID 235)
  Abdelrahman M Galal (The Netherlands)
10:10-10:20 O-002 Bariatric surgery related complications during pregnancy (ID 102)
  Martine Uittenbogaart (The Netherlands)
10:20-10:30 O-003 Trocar site hernia in bariatric surgery- an underestimated problem. A qualitative systematic review (ID 115)
  Ioannis Karampinis (Germany)
09:40-10:30 ORAL COMMUNICATIONS: Metabolic Mechanisms of Surgeries
Chairs Rachel Batterham, Juan Pujol Rafols, John Melissas
09:40-09:50 O-004 Tailored Laparoscopic OAGB as an anti-diabetic procedure in BMI (30-35) (ID 111)
  Ahmed Elsobky (Egypt)
09:50-10:00 O-005 Shortening the biliopancreatic limb length could prevent undernutrition risk while maintaining glucose homeostasis improvement: demonstration in a rat model of One Anastomosis Gastric Bypass (ID 101)
  Maude Le Gall (France)
10:00-10:10 O-006 Incidence of secondary hyperparathyroidism after biliopancreatic diversion with duodenal switch for morbid obesity: an underestimated phenomenon (ID 204)
  Philipp C. Nett (Switzerland)
10:10-10:20 O-007 The impact of bariatric surgery on gut microbiota, diabetes remission and metabolic profile of morbidly obese patients: a comprehensive meta-analysis (ID 55)
  Dimitrios Magouliotis (Greece)
10:20-10:30 O-008 Somatotropic axis (GH/ IGF-1) variations after bariatric surgery in morbidly obese nondiabetic patients (ID 185)
  Maria E. Barmpari (Greece)
  Nikos Skalkotas Hall
Chairs Ralph Peterli, Francois Pattou, George Stavropoulos
11:00-11:20 Place of bariatric/metabolic surgery in adolescents
  Torsten Olbers (Sweden)
11:20-11:40 Is there a role for bariatric/metabolic surgery in patients over 65 yeras of age?
  Pierre Fournier (Switzerland)
11:40-12:00 What is the role of bariatric/metabolic surgrey before or after transplantation?
  Antonio Iannelli (France)
12:00-12:20 Bariatric surgery and psychiatric disorders: Where are the limits?
  Fausta Micanti (Italy)
12:20-12:30 Discussion
11:00-12:30 GREEK  SESSION: Surgical Treatment of Diabetes Type II, Multidisciplinary Approach
Chairs Alberic  Fiennes, Carl le Roux, Nikolaos Tentolouris
11:00-11:15 Metabolic surgery v conventional medical treatment. Overview of RCT’s
  George Skroubis (Greece)
11:15-11:30 Definition of diabetes-specific goals and success of surgical treatment
  Georgios Valsamaki (Greece)
11:30-11:45 What are the limits of the medical treatment of T2DM? When would I refer a patient for surgery?
  Vaia Lambadiari (Greece)
11:45-12:00 It’s all about Incretins, or there is more in the T2DM improvement after metabolic surgery?
  Theodoros Alexandridis (Greece)
12:00-12:15 The role of gut microbiota and bile acids in the effects of bariatric/metabolic surgery on obesity and T2DM
  Emmanouil Papadakis (Greece)
12:15-12:30 Short- and long-term safety of metabolic surgery procedures
  Andreas Alexandrou (Greece)
11:00-12:30 ORAL COMMUNICATIONS: Results of Bariatric Surgeries
Chairs Edo Aarts, Nikolaos Georgopoulos
11:00-11:10 O-009 Omega Loop Gastric Bypass two years follow up –weight loss, early and late complications (ID 74)
  Eliezer Avinoah (Israel)
11:10-11:20 O-010 Banded versus non-banded Roux-en-Y Gastric Bypass for morbid obesity: A meta-analysis (ID 112)
  Dimitrios Magouliotis (Greece)
11:20-11:30 O-011 Outcomes 15 years and beyond following adjustable gastric banding for morbid obesity: high band failure rate with safe revisions (ID 26)
  Catherine Tsai (Switzerland)
11:30-11:40 O-012 Vertical sleeve gastrectomy or Roux-en-Y Gastric Bypass? A Systems epidemiology approach for bariatrics personalized treatment (ID 173)
  Styliani Geronikolou (Greece)
11:40-11:50 O-013 One Anastomosis Gastric Bypass versus sleeve gastrectomy for morbid obesity: a meta-analysis (ID 90)
  Dimitrios Magouliotis (Greece)
11:50-12:00 O-014 One Anastomosis Gastric Bypass versus Roux-en-Y-Gastric Bypass as primary bariatric procedures: Mid-term results with 622 cases from a single institution (ID 148)
  Karl Peter Rheinwalt (Germany)
12:00-12:10 O-015 Evolution of comorbidities at 1, 2 and 5-years follow up after sleeve gastrectomy, Roux-en-Y Gastric Bypass (RYGB) and One Anastomosis Gastric Bypass (OAGB): A comparative study (ID 179)
  Jaime Ruiz-Tovar (Spain)
12:10-12:20 O-016 Simultaneous conversion of gastric band to sleeve gastrectomy: an analysis of 98,298 patients from the MBSAQIP Database (ID 215)
  Nestor De La Cruz-Munoz (USA)
12:20-12:30 Discussion
  Nikos Skalkotas Hall
Chairs Philippe Topart, Jerome Dargent, Evangelos Nanos
14:30-14:50 Standard RYGB
  Harry Pappis (Greece)
14:50-15:10 OAGB
  Konstantinos Albanopoulos (Greece)
15:10-15:30 Long biliary limb
  Frits Berends (The Netherlands)
15:30-15:50 Banded bypass
  Edo Aarts (The Netherlands)
15:50-16:00 Discussion
14:30-16:00 ORAL COMMUNICATIONS: Surgery of Diabetes. A New Era
Chairs Dror Dicker, Marco Bueter
14:30-15:00 Why and when to operate on Diabetes
  Scott Shikora (USA)
15:00-15:10 O-017 Standardized peri- and postoperative treatment protocol in insulin dependent type 2 diabetes patients undergoing Roux-en-Y Gastric Bypass surgery (ID 32)
  Laura Deden (The Netherlands)
15:10-15:20 O-018 Have National Institute for Health and Care Excellence (NICE) Guidelines for people with type 2 diabetes and obesity been implemented in the UK? (ID 247)
  Roxanna Zakeri (UK)
15:20-15:30 O-019 Laparoscopic sleeve gastrectomy improves diabetes mellitus in the long term (ID 154)
  Ioannis-Petros Katralis (Greece)
15:30-15:40 O-020 Roux-en-Y Gastric Bypass leads to superior improvements in fasting and postprandial glycemic and lipid profile than sleeve gastrectomy (ID 139)
  Chrysi Koliaki (Greece)
15:40-15:50 O-021 Time to glycemic control -- an observational study of 3 different operations (ID 131)
  Sjaak Powels (The Netherlands)
15:50-16:00 O-022 Metabolic Surgical Outcomes in a United States Appalachian Population (ID 248)
  Makenzie Barr (USA)
Chairs Luigi Angrisani, Alexander Neimark, George Spiliopoulos
14:30-14:40 O-023 Revisional surgery - Change of frequency and type revisional surgery during last 3 decades (ID 130)
  Rudolf Weiner (Germany)
14:40-14:50 O-024 OAGB and its Early Compilations - Data From 921 Consecutive Operations (ID 64)
  Yonatan Lessing (Israel)
14:50-15:00 O-025 Mid- and long-term evolution  of weight loss after sleeve gastrectomy (SG), Roux-en-Y Gastric Bypass (RYGB) and One Anastomosis Gastric Bypass (OAGB): A comparative study (ID 178)
  Jaime Ruiz-Tovar (Spain)
15:00-15:10 O-026 Long-term follow-up of older patients with super obesity and biliopancreatic diversion with duodenal switch (ID 174)
  Philipp C. Nett (Switezrland)
15:10-15:20 O-027 Are there ideal bowel lenghts to obtain optimal weight loss after One Anastomosis Gastric Bypass (OAGB)? (ID 180)
  Jaime Ruiz-Tovar (Spain)
15:20-15:30 O-028 Comparative evaluation of Pylorus-preserving types of Biliopancreatic Diversion (SADI’s vs. Switch) (ID 76)
  Yury Yashkov (Russia)
15:30-15:40 O-029 Weight regain after gastric sleeve operation: our experience with SADI- S Bypass (ID 194)
  Vasiliki Christogianni (Greece)
15:40-15:50 O-030 Safety and Effectiveness of OAGB (ID 22)
  Asnat Raziel (Israel)
15:50-16:00 Discussion
  Nikos Skalkotas Hall
16:30-18:00 REVISIONAL Sleeve Gastrectomy
Chairs Jean-Marc Chevallier, Torsten Olbers, George Tzovaras
16:30-16:45 When to revise and which procedures? - Introduction
  Rachel Batterham (UK)
16:45-17:00 When to revise and which procedures? Reflux / Barrett
  Gerhard Prager (Austria)
17:00-17:15 Sleeve to DS
  Philippe Topart (France)
17:15-17:30 Surgical options - Sleeve to RYGB
  Antonio Iannelli (France)
17:30-17:45 Surgical options - Sleeve to SADI
  Esteban Martin Antona (Spain)
17:45-18:00 Surgical options -  Sleeve to OAGB
  George Skroubis (Greece)
16:30-18:00 YOUNG IFSO
Chairs Luigi Angrisani, Catalin Copaescu, Vasilis Drakopoulos
16:30-16:45 Treatment algorithm for a failed bypass
  Bruno Dillemans (Belgium)
16:45-16:55 O-031 Low food access ranking among West Virginia Appalachian metabolic surgery patients (ID 249)
  Melissa Olfert (USA)
16:55-17:05 10 years results bypass vs sleeve-results from a patients survey
  Sylvia Weiner (Germany)
17:05-17:15 O-032 Initial experience of endoscopic radiofrequency waves delivery to the lower oesophageal sphincter (Stretta procedure) on symptomatic Gastroesophageal reflux disease post sleeve gastrectomy (ID 82)
  Nesreen Khidir (Quatar)
17:15-17:25 O-033 Side-side jejunoileal anastomosis as a revisional procedure in failed sleeve gastrectomy (ID 203)
  Eren Taskin (Turkey)
17:25-17:35 New bariatric procedures – past or future?
  Aleksandr Neimark (Russia)
17:35-17:45 O-034 Comparative study of medical versus surgical weight loss in elderly: Cardiometabolic and nutritional changes at one year follow up (ID 209)
  Moamena El-Matbouly (Quatar)
17:45-17:55 O-035 The adjustabile gastric bands - is there time to say good bye? (ID 134)
  Karin Dolezalova (Czech Republic)
16:30-18:00 ORAL COMMUNICATIONS: Metabolic Effects of Surgeries
Chairs Rudolf Weiner, Yuri Yaskhov, Evangelos Menenakos
16:30-16:40 O-036 Gastric bypass specifically alters liver parameters as compared to sleeve gastrectomy, independently of steatosis evolution, one year after surgery (ID 15)
  Séverine Ledoux (France)
16:40-16:50 O-037 Transient elastography for the assessment of NAFLD in bariatric/metabolic patients- a real life setting (ID 157)
  Magdalena Eilenberg (Austria)
16:50-17:00 O-038 Sugar detection threshold after laparoscopic sleeve gastrectomy in adolescents (ID 69)
  Ghalia N. Abdeen (Saudi Arabia)
17:00-17:10 O-039 How often do restrictive bariatric operations cause metabolic deficiencies? (ID 152)
  Ioannis-Petros Katralis (Greece)
17:10-17:20 O-040 Direct measurement of macronutrient intake and preference 1 year after Roux-en-Y Gastric Bypass (RYGB) (ID 238)
  Natasha Kapoor (Ireland)
17:20-17:30 O-041 Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery (ID 103)
  Martin Fried (Czech Republic)
17:30-17:40 O-042 Effects of sleeve gastrectomy on the expression and dna methylation of human intermediary metabolism, inflammation and weight control-related genes in whole blood (ID 167)
  Marc Beisani (Spain)
17:40-17:50 O-043 Single Anastomosis Duodenal Ileal bypass with Sleeve Gasterctomy versus Roux-en-Y Gastric Bypass: comparison of results on glycemic homeostasis and weight loss. A murine model (ID 30)
  Laura Montana (France)
17:50-18:00 O-044 Monocyte subpopulations in peripheral blood are suitable for non-invasive diagnosis of NASH in patients with obesity (ID 93)
  Katharina Staufer (Austria)
  Nikos Skalkotas Hall
Chairs TBA
  Ancient Greek Surgery inspiring Current Practice
  Vassilios Golematis (Greece)


Friday, May 18

  Nikos Skalkotas Hall
Chairs Martin Fried, Sylvia Weiner, Nicholas Katsilambros
09:00-09:30 Gut hormones, enterokines and gut-derived lipid mediators
  Rachel Batterham  (UK)
09:30-09:55 Bile acids; are they the new gut hormones?
  Dimitri Pournaras (UK)
09:55-10:20 Implications of Gut microbiota changes after bariatric surgery
  Nuria Vilarrasa (Spain)
10:20-10:30 Discussion
09:00-10:30 ORAL COMMUNICATIONS: Miscellaneous I
Chairs Roel Bolckmans, Karin Dolezalova, Konstantinos Milias
09:00-09:10 O-045 Preoperative education and informed consent in young adults undergoing bariatric surgery: patients’ perspectives on current practice (ID 116)
  Danielle Bonouvrie (The Netherlands)
09:10-09:20 O-046 Bariatric surgery and incidental gastrointestinal stromal tumors – a single-center study (ID 169)
  Orestis Lyros (Germany)
09:20-09:30 O-047 Obesity as a determinant of post-operative outcome in patients following colorectal cancer surgery: a population based study (2009-2016) (ID 12)
  Youri Poelemeijer (The Netherlands)
09:30-09:40 O-048 Proven post-op weight maintenance factors and behavioral follow-through using Acceptance Commitment Therapy, Motivational Enhancement Therapy and Dialectical Behavior Therapy techniques by the entire multidisciplinary team (ID 207)
  Connie Stapleton (USA)
09:40-09:50 O-049 Blind loop syndrom after Roux-en-Y Gastric Bypass (ID 46)
  Volker Lange (Germany)
09:50-10:00 O-050 Transitory jejuno-gastric intussesception as a potential cause of epigastric pain and dyspepsia after the gastric bypass surgery (ID 9)
  Yaroslav Isaev (Germany)
10:00-10:10 O-051 Over three years results of hiatal hernia repair with mesh in a single institution (ID 170)
  Angelo Iossa (Italy)
10:10-10:20 O-052 Alcohol And WLS: It’s a problem the multidisciplinary team needs to address! (ID 210)
  Connie Stapleton (USA)
10:20-10:30 Discussion
09:00-10:30 ORAL COMMUNICATIONS: Revisional Surgeries
Chairs Richard Welbourn, George Skroubis, Eren Taskin
09:00-09:10 O-053 Single Anastomosis Duodenoileal bypass versus Roux-en-Y Gastric Bypass following failed Sleeve Gastrectomy: A Multicenter Cohort study (ID 146)
  Phillip Dijkhorst (The Netherlands)
09:10-09:20 O-054 Conversion of Both Versions of Vertical Banded Gastroplasty to Laparoscopic Roux-en-Y Gastric Bypass, Analysis of Short-term Outcomes (ID 95)
  Talal Khewater (Belgium)
09:20-09:30 O-055 Outcome of revisional bariatric surgery for insufficient weight loss after laparoscopic Roux-en-Y Gastric Bypass (ID 200)
  Katja Allgaier (Switzerland)
09:30-09:40 O-056 Weight regain after vertical gastric plication: Sleeve gastrectomy or Roux-en-Y Gastric Bypass as a salvage procedure? Analysis of the first 300 consecutive patients (ID 100)
  Elie Chouillard (France)
09:40-09:50 O-057 The failed Roux-en-Y Gastric Bypass:  band or distalization? (ID 41)
  Abel Boerboom (The Netherlands)
09:50-10:00 O-058 Revision in 1000 consecutive Patients Who Had Sleeve Gastrectomy for Morbid Obesity in a Single Center (ID 98)
  Elie Chouillard (France)
10:00-10:10 O-059 Outcome and risks of surgical reintervention for weight regain after RYGB (ID 150)
  Daniel Moritz Felsenreich (Austria)
10:10-10:20 O-060  Lack of Uniform Definition of Success, Failure and Weight Regain After Primary Roux-en-Y Gastric Bypass and Gastric Sleeve (ID 104)
  Danielle Bonouvrie (The Netherlands)
10:20-10:30 Discussion
  Nikos Skalkotas Hall
Chairs Luca Busetto, Harry Pappis
11:00-11:20 How to select and prepare a patient for surgery
  Dror Dicker (Israel)
11:20-11:40 How to decide the type of bariatric /metabolic procedure in the individual cases
  Ralph Peterli (Switzerland)
11:40-12:00 How to improve the availability and the safety of bariatric procedures
  Rachel Batterham (UK)
12:00-12:20 How to build an effective long-term follow-up
  Luca Busetto (Italy)
12:20-12:30 Discussion
11:00-12:30 ORAL COMMUNICATIONS: Sleeve Gastrectomy
Chairs Gerhard Prager, Antonio Iannelli, Dimitrios Lapatsanis
11:00-11:10 O-061 Gastroesophageal reflux disease following LSG: a prospective study (ID 193)
  Viktoria Michalopoulou (Greece)
11:10-11:20 O-062 Incidence of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy with staple line reinforcement with oversewing and staple line inversion vs buttressing material (ID 184)
  Jaime Ruiz-Tovar (Spain)
11:20-11:30 O-063 Pushing the limits in bariatric surgery: sleeve gastrectomy for morbidly obese patients over 65 years old (ID 19)
  Panagiotis Lainas  (France)
11:30-11:40 O-064 Food tolerance and quality of alimentation following laparoscopic sleeve gastrectomy calibrated with a 50-Fr bougie: Long-term results (ID 187)
  Jaime Ruiz-Tovar (Spain)
11:40-11:50 O-065 Preoperative detection of sarcopenic obesity helps to predict the occurrence of gastric leak after sleeve gastrectomy (ID 17)
  Panagiotis Lainas (France)
11:50-12:00 O-066 The comparative analysis of sleeve gastrectomy with and without antrumectomy (ID 37)
  Taryel Omerov (Azerbaijan)
12:00-12:10 O-067 Nine-Year experience with laparoscopic sleevegastrectomy in a tertiary public hospital in Greece (ID 236)
  Angeliki Kolinioti (Greece)
12:10-12:20 O-068 The endoscopic-vacuum assisted closure-technique in the treatment of staple line leaks after sleeve gastrectomy (ID 137)
  Vasiliki Christogianni (Greece)
12:20:12:30 Discussion
11:00-12:30 ORAL COMMUNICATIONS: Endoluminal & Innovative Procedures, incl. Robotics
Chairs Alberic Fiennes, Marco Bueter, Andreas Alexandrou
11:00-11:20 Robotics in bariatric surgery: My view
  Scott Shikora (USA)
11:20-11:30 O-069 Results of the Crossover Group in the Randomized Controlled Multicenter MILEPOST Study for Primary Obesity (POSE) vs. Diet-Exercise alone (ID 168)
  Karl Miller (Austria)
11:30-11:40 O-070 Reversible gastric bypass with fundectomy and gastric remnant exploration (lrygbfse): results at 5-years follow-up (ID 34)
  Giovanni Lesti (Italy)
11:40-11:50 O-071 Elipse® Swallowable Intragastric  Balloon + Very Low Calorie Ketogenic Diet (VLCKD): A Novel Strategy to Optimize Weight-Loss and Minimize Side Effects (ID 243)
  Roberta Ienca (Italy)
11:50-12:00 O-072 Modified laparoscopic Sleeve Gastrectomy combined with Rossetti fundoplication (R-Sleeve): midterm results after more than 170 procedures (ID 158)
  Matteo Uccelli (Italy)
12:00-12:10 O-073 Magenstrasse and Mill procedure with Nissen-Rossetti fundoplication as an alternative option for bariatric patients with gastroesophageal reflux or hiatal hernia (ID 21)
  Bernard Majerus (Belgium)
12:10-12:20 O-074 Robotic versus conventional laparoscopic minigastric bypass: is innovation always better? (ID 161)
  Hakan Karatas (Turkey)
12:20-12:30 O-075 Effect of the EndoBarrier Device: a 4-year follow up of a multicenter randomized clinical trial (ID 51)
  Yvonne Roebroek (The Netherlands)
  Nikos Skalkotas Hall
Chairs Theodor K. Alexandrides, Michel Suter
14:30-14:50 Management of extreme obesities
  Gerhard Prager (Austria)
14:50-15:10 Pre and post-operative deficiencies: the reality
  Johanna Brix (Austria)
15:10-15:30 Post bariatric hypoglycaemia: diagnosis and medical solutions
  Andrea Pucci (UK)
15:30-15:50 Abdominal pain after bariatric surgery: prevalence, evaluation, management
  Martin Fried (Czech Republic)
15:50-16:00 General discussion
Chairs Rachel Batterham, Luca Busetto, Alexander Kokkinos
14:30-15:00 Introductory lecture
  Marco Bueter (Switzerland)
15:00-15:10 O-076 Determination of underlying genetic variations in an obese cohort of more than 1000 patients and the effect of bariatric surgery (ID 68)
  Mellody Cooiman (The Netherlands)
15:10-15:20 O-077 Appetite, glycemia, and entero-insular hormone responses differ between oral, gastric-remnant, and duodenal administration of a mixed meal test after Roux-en-Y Gastric Bypass (ID 10)
  Daniel Gero (Switzerland)
15:20-15:30 O-078 Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-Cell peptides: Results from the HIPER-1 study (ID 132)
  Sjaak Powels (The Netherlands)
15:30-15:40 O-079 Reduction in Iron deficiency after Sleeve gastrectomy in women, a prospective controlled cohort study (ID 177)
  Zoubida Karim (France)
15:40-15:50 O-080 Sleeve gastrectomy: Does the procedure impact gut hormones or the induced weight loss does (ID 113)
  Panagiotis Patrikakos (Greece)
15:50-16:00 O-081 Taste sensitivity to dietary fat before and after bariatric surgery:  A cross-sectional study of oleic acid taste detection thresholds with correlation to GLP-1 profiles (ID 87)
  Janine Makaronidis (UK)
14:30-16:00 VIDEO SESSION:  Interesting Cases & Conversions
Chairs Esteban Martin Antona, Luigi Angrisani, Konstantinos Albanopoulos
14:30-14:40 V-001 Surgical treatment for Nesidioblastosis after Roux-en-Y Gastric Bypass (ID 23)
  Hadar Nevo (Israel)
14:40-14:50 V-002 Prevention of reflux-esophagitis after laparoscopic sleeve gastrectomy  by creating a three-chambered gastric sleeve (ID 89)
  Olesya Starzhinskaya, Arut Mezhunts (Russia)
14:50-15:00 V-003 Early small bowel obstruction after bariatric surgery: strategy for successful laparoscopic management (ID 225)
  Charalampos Markakis (Greece)
15:00-15:10 V-004 Postoperative case:  Unusual case of an upper GI bleeding years after Roux-en-Y Gastric Bypass (ID 221)
  Maria Solovyeva (Russia)
15:10-15:20 V-005 Redo laparoscopic sleeve gastrectomy. Technical aspects to prevent stenosis and late leak subsequent to stomach antrum twisting (ID 256)
  Georgios Ayiomamitis (Greece)
15:20-15:30 V-006 Solution of severe reflux post LSG, post RNY: Toupet “fundoplication” with the remnant sleeve stomach (case report) (ID 252)
  Farah Ibrahim Bakhit Juma (United Arab Emirates)
15:30-15:40 V-007 Laparoscopic repair of giant hiatus hernia and Roux-en-Y Gastric Bypass (ID 159)
  Lydia Eleni Oannidi (UK)
15:40-15:50 V-008 Laparoscopic conversion from vertical banded gastroplasty with hiatal hernia associated to Roux-en-Y Gastric Bypass (ID 159)
  Maria Recarte (Spain)
15:50-16:00 V-009 Laparoscopic conversion of gastric bypass into sleeve gastrectomy (ID 140)
  Romano Schneider (Switzerland)
  Nikos Skalkotas Hall
Chairs Ralph Peterli, Odysseas Voudouris
16:30-16:45 Long term results of LAGB
  Stelios Kapiris (Greece)
16:45-17:00 Long term results of SG
  Dimitris Zacharoulis (Greece)
17:00-17:15 Long term results of RYGB
  Michel Suter (Switzerland)
17:15-17:30 Long term results of BPD-DS
  Roel Bolckmans (Belgium)
16:30-17:30 ORAL COMMUNICATIONS: Miscellaneous II
Chairs Dimitri Pournaras, Karl Miller, Georgios Ayiomamitis
16:30-16:40 O-082 First things first: pregnancy or bariatric surgery? (ID 143)
  Edo Aarts (The Netherlands)
16:40-16:50 O-083 Laparoscopic sleeve gastrectomy for morbidly obese patients under 18 years-old (ID 27)
  Panagiotis Lainas (France)
16:50-17:00 O-084 Bariatric surgery in the elderly: is sleeve gastrectomy a feasible option (ID 153)
  Athanasios Pantelis (Greece)
17:00-17:10 O-085 Weight loss, Reduction of Comorbidities and Quality of Life after Bariatric Surgery in the Elderly (ID 52)
  Mellody Cooiman (The Netherlands)
17:10-17:20 O-086 Multi-centre, intraoperative micro-costing of Roux-en-Y Gastric Bypass, adjustable gastric banding and sleeve gastrectomy procedures for the treatment of severe, complex obesity in the United Kingdom (ID 39)
  Brett Doble (UK)
17:20-17:30 O-087 Association between cardiorespiratory fitness and excess weight loss after sleeve gastrectomy (ID 181)
  Paulina Ibacache (Chile)
16:30-17:00 VIDEO SESSION: Redo Cases
Chairs Fausta Micanti, Emmanuel Leandros
16:30-16:40 V-010 Re-sleeve with silastic ring and crurorhaphy in a rare case of severe hyperinsulimic hypoglycemia after sleeve gastrectomy (ID 53)
  Catherine Tsai (Switzerland)
16:40-16:50 V-011 Laparoscopic Reversal of Roux-en-Y Gastric Bypass (LRYGB) (ID 29)
  Ron Dar (Israel)
16:50-17:00 V-012 Failed sleeve gastrectomy: 3 surgical proposals (ID 176)
  Konstantinos Albanopoulos (Greece)
17:00-17:10 V-013 Gastric bypass as conversion from abandoned bariatric procedures: gastric plication, banding or pacemaker, toga or banded vertical gastroplasty.  A video remix (ID 171)
  Cristian Boru (Italy)
17:10-17:20 V-015 Salvation gastric bypass as conversion from failed, open banded vertical gastroplasty (ID 246)
  Cristian Boru (Italy)
17:20-17:30 Discussion
17:30-18:30 General Council
20:00 Farewell Event


Saturday, May 19

  Nikos Skalkotas Hall
09:00-11:00 DEBATE: Band, Sleeve or Bypass
Chairs Antonio Torres, Maurizio De Luca, Stelios Kapiris
09:00-09:20 SLEEVEPASS
  Paulina Salminen (Finland)
09:20-09:40 SM-BOSS
  Ralph Peterli (Switzerland)
09:40-10:00 Evidence for Sleeve
  David Nocca (France)
10:00-10:20 Evidence for bypass
  Catalin Copaescu (Romania)
10:20-10:40 Roux-en-Y or One Anastomosis Gastric Bypass
  John Melissas (Greece)
10:40-11:00 What is the current place (if any) for gastric banding?
  Jean-Marc Chevallier (France)
09:00-10:40 ORAL COMMUNICATIONS: Integrated Health
Chairs Luigi Angrisani, Frits Berends, Christos Zoupas
09:00-09:10 O-088 Taste makes waist? The relationship between energy intake and weight loss in Dutch bariatric patients (ID 50)
  Laura Deden (The Netherlands)
09:10-09:20 O-089 Determination of slimming effect by auricular Acupuncture stimulation -Statistical analysis of 1500 female data (ID 35)
  Takahiro Fujimoto (Japan)
09:20-09:30 O-090 Serum uromodulin in diabetic nephropathy (ID 160
  Katharina Scheurlen (Germany)
09:30-09:40 O-091 Histopathology Findings in Patients Undergoing Laparoscopic Sleeve Gastrectomy (ID 165)
  Angelo Iossa (Italy)
09:40-09:50 O-092 Bariatric surgery for people with intellectual disability (ID 5)
  Julia Hilbert (Germany)
09:50-10:00 O-093 The effect of bariatric surgery on direct oral anticoagulant activity of rivaroxaban after bariatric surgery: the extension study (ID 164)
  Dino Kröll (Switzerland)
10:00-10:10 O-094 Multipurposed Abdominoplasty after bariatric surgery (ID 75)
  Yury Yashkov (Russia)
10:10-10:20 O-095 The Effects of Protein-Riched Diet, Performed Before Bariatric Surgery, On Losing Weight, Clinical Results And Liver Volume Reduction (ID 245)
  Nihal Zekiye Erdem (Turkey)
10:20-10:30 O-096 A structured approach to airway management in the morbidly obese patient: the experience of a high volume bariatric center at Humanitas Research Hospital (Italy) (ID 54)
  Chiara Ferrari (Italy)
10:30-10:40 Discussion
09:00-10:40 ORAL COMMUNICATIONS: Multidisciplinary
Chairs Marco Bueter, Efthimios Kapantais
09:00-09:10 O-097 The effect of pre-surgery information online lecture on nutrition-knowledge and anxiety among bariatric surgery candidates (ID 20)
  Shiri Sherf-Dagan (Israel)
09:10-09:20 O-098 Attendance of follow-up visits after bariatric  operation within 5 years (ID 45)
  Anke Rosenthal (Germany)
09:20-09:30 O-099 Interpersonal characters among bariatric candidates compared to control group (ID 117)
  Inbal Globus (Israel)
09:30-09:40 O-100 How to treat iron deficiencies after RYGB: outcomes of an RCT (ID 213)
  Edo Aarts (The Netherlands)
09:40-09:50 O-101 Vitamin, trace element and protein status of patients undergoing Single Anastomosis Gastric Bypass (ID 191)
  Julia Jedamzik (Austria)
09:50-10:00 O-102 Metabolic Surgeons self-assessing sexual health issues in disease management of morbid obese patients at the Austrian Congress of Surgeons, June 2017 (ID 228)
  Lucia Ucsnik (Austria)
10:00-10:10 O-103 Do specialized bariatric multivitamins lower deficiencies after RYGB? (ID 142)
  Edo Aarts (The Netherlands)
10:10-10:20 O-104 Effects of preoperative  nutritional supplements enriched with Omega-3 fatty acids on postoperative pain and analytical acute-phase reactants in  patients undergoing Roux-en-Y Gastric Bypass (ID 196)
  Jaime Ruiz-Tovar (Spain)
10:20-10:30 O-105 Nutritional management of bariatric surgery patients in order to attenuate bone deterioration (ID 3)
  Tair Ben-Porat (Israel)
10:30-10:40 Discussion
11:00-11:30 COFFEE BREAK
  Nikos Skalkotas Hall
Chairs Michel Suter, Gerhard Prager, Harry Pappis
11:30-11:50 Overview of the evidence
  Marco Bueter (Switzerland)
11:50-12:10 Experience in Israel
  Nasser Sakran (Israel)
12:10-12:30 Experience in the UK
  Richard Welbourn (UK)
12:30-12:50 Experience in Italy
  Luigi Angrisani (Italy)
12:50-13:00 Round table discussion
Chairs Alberic Fiennes, Ralph Peterli, Rachel Batterham
11:30-11:40 O-106 The impact of Roux-en-Y Gastric Bypass on bone remodelling expressed by the P1NP/βCTX ratio: a single-center prospective cohort study (ID 43)
  Daniel Gero (Switzerland)
11:40-11:50 O-107 Beta cells in patients with changes in glycemic control after Roux-en-Y Gastric Bypass surgery, visualized by 68Ga-exendin-4 PET/CT (ID 16)
  Laura Deden (The Netherlands)
11:50-12:00 O-108 Features of oral glucose tolerance test in patients with and without late dumping after Roux-en-Y Gastric Bypass: it’s all about speed (ID 77)
  Ilke Marien (Belgium)
12:00-12:10 O-109 Dumping syndrome after gastric bypass: endoluminal revision of the dilated gastrojejunostomy is a safe and highly effective treatment option (ID 25)
  Catherine Tsai (Switzerland)
12:10-12:20 O-110 Impact of implementation of an Enhanced Recovery After Surgery (ERAS) program in in laparoscopic Roux-en-Y Gastric Bypass: A prospective randomized clinical trial (ID 183)
  Jaime Ruiz-Tovar (Spain)
12:20-12:30 O-111 Gastro-esophageal reflux disease one year after One Anastomosis Gastric Bypass (ID 190)
  Viktoria Michalopoulou (Greece)
12:30-12:40 O-112 Long-term weight loss after Roux-en-Y Gastric Bypass is independant from age at baseline (ID 114)
  Styliani Mantziari (Switzerland)
12:40-12:50 O-113 Band and Extend? Results of 2 randomized controlled trials on RYGB improvement (ID 42)
  Abel Boerboom (The Netherlands)
12:50-13:00 O-114 Procalcitonin (PCT) as a marker of postoperative complications in bariatric surgery. A prospective study (ID 73)
  Laura Montana (France)
11:30-13:00 ORAL COMMUNICATIONS: Allied Health
Chairs Jean-Marc Chevallier, Martin Fried, Maria Yannakoulia
11:30-11:40 O-115 Pre-operative Very Low Calory Ketogenic Diet (VLCKD) vs. Very Low Calory Diet (VLCD): Surgical impact (ID 260)
  Alice Albanese (Italy)
11:40-11:50 O-116 The influence of body weight on brain function and structure. The BARICO study: study rationale and protocol (ID 38)
  Debby Vreeken (The Netherlands)
11:50-12:00 O-117 Obstructive sleep apnea in obese patients; postoperative outcomes of postoperative pulse oximetry without preoperative OSA screening (ID 133)
  Sophie L. van Veldhuisen (The Netherlands)
12:00-12:10 O-118 Self-efficacy in weight management, patient satisfaction and lifestyle habits after standard gastric bypass (ID 119)
  Alexia Katsarou (Greece)
12:10-12:20 O-119 Comparison of nutritional status and neonatal outcomes in pregnant women after Roux-en-Y Gastric Bypass and sleeve gastrectomy (ID 14)
  Muriel Coupaye (France)
12:20-12:30 O-120 Nutritional status of vegetarian candidates for laparoscopic sleeve gastrectomy (ID 2)
  Shiri Sherf-Dagan (Israel)
12:30-12:40 O-121 The role of adjuvant pharmacotherapy in the management of patients with a partial response to bariatric metabolic surgery-the first Australian experience (ID 233)
  Georgia Rigas (Australia)
12:40-12:50 O-122 Bariatric surgery as a salvage operation in critically ill/septic superobese patients - an option? (IS 81)
  Kamil Yamac (Germany)
12:50-13:00 O-123 Analgesic effect of laparoscopic-guided Transversus Abdominis Plane blockade vs Port-site infiltration as analgesic multimodal approach after Roux-en-Y Gastric Bypass: A prospective randomized study (ID 189)
  Jaime Ruiz-Tovar (Spain)
13:00-13:30 Closing Ceremony


© 2021 GUARANT International spol. s r. o.